4//SEC Filing
Eiger BioPharmaceuticals, Inc. 4
Accession 0001209191-16-138029
CIK 0001305253operating
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 7:15 PM ET
Size
8.8 KB
Accession
0001209191-16-138029
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2016-08-18$15.70/sh+1,562$24,523→ 58,451 total
Holdings
- 30,350(indirect: See footnote 1)
Common Stock
Footnotes (1)
- [F1]Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeoperating
Related Parties
1- filerCIK 0001305253
Filing Metadata
- Form type
- 4
- Filed
- Aug 18, 8:00 PM ET
- Accepted
- Aug 19, 7:15 PM ET
- Size
- 8.8 KB